Efficacy and Safety of Pueraria Lobata Radix As an Adjuvant Treatment for Type 2 Diabetes Mellitus

Recruiting 200 enrolled Jiangxi University of Traditional Chinese Medicine The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine · collab The First Affiliated Hospital of Nanchang University · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

As a dietary herb, pueraria lobata radix (PLR) has been showed to have hypoglycemic effects in animal experiments. However, there is currently a lack of evidence from randomized controlled trials. Therefore, this randomized, double-blind, placebo-controlled trial aims to assess the efficacy and safety of PLR as an adjunctive treatment for type 2 diabetes mellitus (T2DM).

Timeline

Start: 2024-07-25
Primary completion: 2025-12-30
Completion: 2025-12-30

Publications

Chen J, Wang J, Yuan L, Xue Q, Zhou J, Ye X, Fan Q, Feng R, Li C, Zhang Y, Zhu W, Li Z, Zhou X. Efficacy and safety of Pueraria lobata radix as an adjuvant therapy for type 2 diabetes mellitus: rationale, design and protocol for a randomised controlled trial. BMJ Open. 2025 May 24;15(5):e092050. doi: 10.1136/bmjopen-2024-092050.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Pueraria lobata radix	Unknown	1.5 g	—

Efficacy and Safety of Pueraria Lobata Radix As an Adjuvant Treatment for Type 2 Diabetes Mellitus

Summary

Timeline

Publications

Drugs

Indications